Article Data

  • Views 1248
  • Dowloads 139

Case Reports

Open Access

Malignant mixed mUllerian tumor of the fallopian tube coincident with a primary serous carcinoma of the ovary. Case report

  • L. Nappi1
  • U. Indraccolo1,*,
  • M. Matteo1
  • P. Rosenberg1
  • P. Greco1

1Department Surgical Sciences, Division of Obstetrics and Gynecology, University of Foggia, Italy

DOI: 10.12892/ejgo200706511 Vol.28,Issue 6,November 2007 pp.511-512

Published: 10 November 2007

*Corresponding Author(s): U. Indraccolo E-mail:

Abstract

Malignant mixed müllerian tumors are very rare neoplasms of the fallopian tube, and treatment is not well defined. A case of malignant mixed müllerian tumor of the tube concomitant with a primary serous carcinoma of the ovary is reported. It was unclear if there were two distinct neoplasms in the same patient, or if it was a single tumor with a sarcomatous fallopian conversion of the serous component, as described for some recurrent ovarian carcinomas. Chemotherapy for ovarian carcinoma with intraperitoneal metastasis was performed, with about a three-year interval-free period of disease, as could be expected for ovarian carcinomas at the same stage. Such coexistence of these two tumors does not afford adequate staging of the malignancy. Therapy for the very rare cases similar to the one reported here needs to be improved.

Keywords

Malignant mixed miillerian tumor; Serous ovarian cancer; Therapy

Cite and Share

L. Nappi,U. Indraccolo,M. Matteo,P. Rosenberg,P. Greco. Malignant mixed mUllerian tumor of the fallopian tube coincident with a primary serous carcinoma of the ovary. Case report. European Journal of Gynaecological Oncology. 2007. 28(6);511-512.

References

[1] Gaducci A., Landoni F., Sartori E., Maggino T., Zola P., Gabriele A. et al.: "Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study". Gynecol. Oneal., 2001, 81, 150.

[2] Obermair A., Taylor K.H., Janda M., Nicklin J.L., Crandon A.J., Perrin L.: "Primary fallopian tube carcinoma: the Queensland experience". Int. J. Gynecol. Cancer, 2001, 11, 69.

[3] Butler D.F., Bolton M.E., Spanos W.J. Jr., Day T.G. Jr., Paris K.J., Jose B.O. et al.: "Retrospective analysis of patients with primary fallopian tube carcinoma treated at the University of Louisville". J. Ky Med. Assoc., 1999, 97, 154.

[4] Gagner J.P., Mittal K.: "Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma". Gynecol. Oneal., 2005, 97, 219.

[5] Ajithkumar T.V., Minimole A.L., John M.M., Ashokkumar O.S.: "Primary fallopian tube carcinoma". Obstet. Gynecol. Surv., 2005, 60,247.

[6] LimB.J.,凡m J.W., Yang W.I., Cho N.H.: "Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components". Int. J. Gynecol. Cancer, 2004, 14, 690.

[7] Piura B., Rabinovich A., Meirovitz M., Yanai-lnbar I.: "Miillerian adenosarcoma of the uterus: case report and review of literature". Eur. J. Gynaecol. Oneal., 2000, 21, 387.

[8] Benedet J.L., Bender H., Jones 3rd H., Ngan H.Y., Pecorelli S.: "FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers". FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet., 2000, 70, 209.

[9] Sreenan J.J., Hart W.R.: "Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis". Am. J. Surg. Pathol., 1995, 19, 666.

[10] Piek J.M., Kenemans P., Verheijen R.H.: "Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause". Am. J. Obstet. Gynecol., 2004, 191, 718.

[11] Callister M., Ramondetta L.M., Jhingran A., Bruke T.W., Eifel P.J.: "Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome". Int. J. Radiat. Oncol. Biol. Phys., 2004, 58, 786.

Submission Turnaround Time

Top